Award
National Cancer Institute 5R01CA259469-05
Systems biology of intratumoral heterogeneity in glioblastoma
Recipient
Institute for Systems Biology, Seattle, WA
Award Amount
$735,737.00
Ceiling
$735,737.00
Awarded
January 12, 2026
Identifier
5R01CA259469-05
Award for a research project studying glioblastoma heterogeneity and drug resistance using advanced single-cell and multi-omics techniques, aiming to improve treatment strategies.
Description
Research project focused on single-cell profiling, drug resistance, and tumor heterogeneity in glioblastoma using a multi-omics approach including scRNA-seq and scATAC-seq. Emphasis on FDA-approved drugs and drug repurposing to develop methodologies, gain mechanistic insights, and devise drug regimen strategies.